Correlation Between Immunome and Iovance Biotherapeutics

Can any of the company-specific risk be diversified away by investing in both Immunome and Iovance Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immunome and Iovance Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Immunome and Iovance Biotherapeutics, you can compare the effects of market volatilities on Immunome and Iovance Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immunome with a short position of Iovance Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immunome and Iovance Biotherapeutics.

Diversification Opportunities for Immunome and Iovance Biotherapeutics

0.42

Correlation Coefficient

Immunome  Iovance Biotherapeutics

Very weak diversification

The 3 months correlation between Immunome and Iovance is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Immunome and Iovance Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Iovance Biotherapeutics and Immunome is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immunome are associated (or correlated) with Iovance Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Iovance Biotherapeutics has no effect on the direction of Immunome i.e., Immunome and Iovance Biotherapeutics go up and down completely randomly.

Pair Corralation between Immunome and Iovance Biotherapeutics

Given the investment horizon of 90 days Immunome is expected to generate 1.09 times more return on investment than Iovance Biotherapeutics. However, Immunome is 1.09 times more volatile than Iovance Biotherapeutics. It trades about 0.01 of its potential returns per unit of risk. Iovance Biotherapeutics is currently generating about -0.03 per unit of risk. If you would invest  1,404  in Immunome on September 1, 2024 and sell it today you would lose (49.00) from holding Immunome or give up 3.49% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Immunome  vs.  Iovance Biotherapeutics

Immunome

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Immunome has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Immunome is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Iovance Biotherapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Iovance Biotherapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Immunome and Iovance Biotherapeutics

The main advantage of trading using opposite Immunome and Iovance Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immunome position performs unexpectedly, Iovance Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Iovance Biotherapeutics will offset losses from the drop in Iovance Biotherapeutics' long position.

The idea behind Immunome and Iovance Biotherapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.